Oruka Therapeutics (ORKA) Stock: Buy, Sell, or Hold?
ORKA - Oruka Therapeutics, Inc. Common Stock
$82.11
4.83 (6.25%)
▲
5d:
-2.85%
30d:
-10.41%
90d:
-2.9%
HOLD
LOW Confidence
Analysis Updated: Oct 9, 2026 12:00 AM ET
Earnings: Nov 11, 2026
Get Alerted When ORKA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ORKA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ORKA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ORKA is currently trading at $82.11, which is considered oversold relative to its 30-day fair value range of $83.15 to $94.29.
Technical Outlook: Technically, ORKA is in a uptrend. Immediate support is located at $75.83, while resistance sits at $86.51. The stock is showing strong short-term momentum, up 6.2% recently.
Market Sentiment: ORKA scores 77/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $155.00 (+88.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ORKA is in a uptrend. Immediate support is located at $75.83, while resistance sits at $86.51. The stock is showing strong short-term momentum, up 6.2% recently.
Market Sentiment: ORKA scores 77/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $155.00 (+88.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$83.15 -
$94.29
Company Quality Score
69/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
100.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (77/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.2%)
- BULLISH: Trading 88.8% below Wall St target ($155.00)
- CAUTION: Bottoming setup, but lagging the sector by 17% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$83.15 -
$94.29
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$75.83
Resistance Level
$86.51
Current Trend
Uptrend
Technical data as of
Oct 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-28.69
Wall Street Target
$155.00
(+88.8%)
Share & Embed Analysis
Last updated: October 10, 2026 6:50 PM ET
Data refreshes hourly during market hours. Next update: 7:50 PM
Data refreshes hourly during market hours. Next update: 7:50 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ORKA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Joana Goncalves
SELL
7000 shares
2026-04-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$198 | 51 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$110 | 67 BUY |
|
CGON
CG Oncology, Inc. Common… |
STRONG BUY
15 analysts |
$91 | 70 BUY |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$682 | 43 HOLD |
|
IMNM
Immunome Inc |
STRONG BUY
16 analysts |
$35 | 57 HOLD |
